InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Machatha Stephen, Directeur du Développement. Director active across 1 company, notably Aldeyra Therapeutics, Inc.. Cumulatively, 6 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €257k. Activity tracked since 30 March 2022. The latest transaction was filed on 11 August 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Machatha Stephen is Directeur du Développement and is linked to Aldeyra Therapeutics, Inc. (XNAS) as Chief Development Officer. He has 6 filings in total, and across the 6 sampled filings the recorded transactions run from 2022-04-01 to 2025-08-13, with EUR 0 of buys and EUR 257488 of sells, and the modal transaction nature is Sale.